Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm to Distribute University of Zurich Mass Cytometry Analysis Software

NEW YORK (GenomeWeb) – Fluidigm said today that it has signed an agreement with the University of Zurich to globally distribute the institution's histoCAT cytometry imaging software alongside its new Hyperion Imaging System.

Developed in the laboratory of Bernd Bodenmiller at the University of Zurich, histoCAT is designed to aid in the analysis of imaging mass cytometry data. For example, the tool can help examine cellular phenotypes and their interrelationships within a tissue sample, and includes novel algorithms to identify complex relationships between cells in healthy and disease states, Fluidigm said.

Additional details were described in a paper in Nature Methods this August.

"Through this new secondary analysis software, researchers can explore a wider range of new questions in conjunction with the Hyperion Imaging System workflow," Fluidigm President and CEO Chris Linthwaite said in a statement.

Under the agreement, Fluidigm will be selling the Zurich software alongside this new Hyperion system, also launched today. According to the company, Hyperion allows researchers to simultaneously image four to 37 protein markers with minimal background, and offers the ability to utilize up to 135 channels to detect additional parameters.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.